We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Owen Mumford

Owen Mumford Ltd. is an industry leader in the medical device market with a diverse product range including advanced ... read more Featured Products: More products

Download Mobile App





Owen Mumford Presents Cutting-Edge Capillary Blood Sampling Devices for POC Testing

By LabMedica International staff writers
Posted on 15 Nov 2022

Owen Mumford (Oxford, UK) is once again exhibiting at this year’s MEDICA in Düsseldorf, Germany where it is presenting tomorrow’s medical device technology today. More...

Attracting several thousand exhibitors from more than 50 countries, MEDICA is the world’s largest event for the medical sector, where each year, leading individuals from the fields of business, research, and politics converge alongside tens of thousands of decision-makers.

At MEDICA 2022, Owen Mumford is showcasing its pioneering products from three different ranges: safety pen needles, venous blood collection set and capillary blood sampling devices. The company’s portfolio of safety pen needles for insulin injections includes the Unifine SafeControl device which is designed to protect healthcare professionals, balancing both safety and control during the injection process. Compatible with all major brands of injection pens, it is available in a variety of sizes and features a manual push tab for easy, one-handed activation of the safety mechanism. It has both a visual and audible confirmation that the safety mechanism has been activated, making it a dual safety pen needle.

Among Owen Mumford’s featured products at MEDICA is its Unistik Touch safety lancet featuring ground-breaking comfort zone technology which helps to minimize the pain of capillary blood sampling. Unistik Touch safety lancet is designed to make capillary sampling as simple and seamless as possible. With one-touch activation, users can simply press the device against the sample site, allowing it to activate automatically under pressure. Once activated, the needle retracts into the body of the device, minimizing the risk of re-use, cross-infection and injury. At MEDICA 2022, Owen Mumford is also showcasing its recently launched venous blood collection portfolio consisting of new devices such as, the Unistik ShieldLock and Unistik VacuFlip. This range provides safety, comfort and quality for healthcare professionals when performing venous blood collection procedures.

Related Links:
Owen Mumford 


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Monarch Mag Cell-free DNA (cfDNA) Extraction Kit provides isolation of low-abundance cfDNA from a range of biofluids (Photo courtesy of New England Biolabs)

New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids

Circulating cell-free DNA (cfDNA) found in plasma, serum, urine, and cerebrospinal fluid is typically present at low concentrations and is often highly fragmented, making efficient recovery challenging... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.